Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services. ... Read More >

Biotechnology company Freenome and ADC Therapeutics, an oncology drug discovery and development company, announced today that they have signed a biomarker development agreement.... Read More >

Cancer Genetics today reported a 15 percent increase in second quarter revenues on improved performance by its core discovery services operations.... Read More >

Aqualung Therapeutics said on Tuesday that it has been awarded a $225,000 grant from the National Institutes of Health to develop a panel of biomarkers, called CRIT-ICU, for stratifying patients at risk for acute respiratory distress syndrom... Read More >

10x Genomics is looking to raise up to $100 million in an initial public offering, according to documents filed Monday with the US Securities and Exchange Commission.... Read More >

Agilent Technologies reported after the close of the market on Wednesday that its third quarter revenues rose 6 percent year over year, thanks largely to an 11 percent increase in revenues for its diagnostics and genomics business.... Read More >

Brigham and Women's Hospital announced recently that it has opened the Preventive Genomics Clinic, an academically affiliated clinical service to provide comprehensive DNA sequencing, interpretation, and reporting of disease-associated genes... Read More >

Genomind and NeuroFlow recently announced an agreement that combines NeuroFlow's digital health platform with Genomind's genetic testing service with the aim of improving patient wellness and reducing costs across a continuum of care for con... Read More >

IncellDx and Kindstar Global announced recently that they have signed master collaboration and exclusive distribution agreements for three of IncellDx's single-cell immuno-oncology and oncology diagnostic products for China. ... Read More >

GenMark Diagnostics reported after the close of the market on Monday a 23 percent increase in second quarter revenues, driven by strong placements of its ePlex analyzer. ... Read More >